Alliance SOLARIS Trial: Vitamin D3 Fails to Boost Colorectal Cancer Survival
For patients with advanced colorectal cancer, adding high-dose vitamin D3 to standard first-line treatment does not improve progression-free survival, according to the results from the Phase III SOLARIS trial (Alliance A021703) published in the Journal of the American Medical Association. Experimental evidence has suggested that vitamin D may have antineoplastic activity, including effects on tumor…